TY - JOUR
T1 - Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells
AU - Dutertre, Charles Antoine
AU - Becht, Etienne
AU - Irac, Sergio Erdal
AU - Khalilnezhad, Ahad
AU - Narang, Vipin
AU - Khalilnezhad, Shabnam
AU - Ng, Pei Y.
AU - van den Hoogen, Lucas L.
AU - Leong, Jing Yao
AU - Lee, Bernett
AU - Chevrier, Marion
AU - Zhang, Xiao Meng
AU - Yong, Pearly Jean Ai
AU - Koh, Geraldine
AU - Lum, Josephine
AU - Howland, Shanshan Wu
AU - Mok, Esther
AU - Chen, Jinmiao
AU - Larbi, Anis
AU - Tan, Henry Kun Kiaang
AU - Lim, Tony Kiat Hon
AU - Karagianni, Panagiota
AU - Tzioufas, Athanasios G.
AU - Malleret, Benoit
AU - Brody, Joshua
AU - Albani, Salvatore
AU - van Roon, Joel
AU - Radstake, Timothy
AU - Newell, Evan W.
AU - Ginhoux, Florent
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/9/17
Y1 - 2019/9/17
N2 - Human mononuclear phagocytes comprise phenotypically and functionally overlapping subsets of dendritic cells (DCs) and monocytes, but the extent of their heterogeneity and distinct markers for subset identification remains elusive. By integrating high-dimensional single-cell protein and RNA expression data, we identified distinct markers to delineate monocytes from conventional DC2 (cDC2s). Using CD88 and CD89 for monocytes and HLA-DQ and FcεRIα for cDC2s allowed for their specific identification in blood and tissues. We also showed that cDC2s could be subdivided into phenotypically and functionally distinct subsets based on CD5, CD163, and CD14 expression, including a distinct subset of circulating inflammatory CD5−CD163+CD14+ cells related to previously defined DC3s. These inflammatory DC3s were expanded in systemic lupus erythematosus patients and correlated with disease activity. These findings further unravel the heterogeneity of DC subpopulations in health and disease and may pave the way for the identification of specific DC subset-targeting therapies. Using high-dimensional protein and RNA single-cell analyses, Dutertre et al. analyze human dendritic cell and monocyte subsets and identify markers that delineate them and unravel their heterogeneity. They also reveal the presence of inflammatory CD14+ DC3s, a subset of cDC2s, that correlate with disease progression and may be functionally involved in systemic lupus erythematosus immunopathology.
AB - Human mononuclear phagocytes comprise phenotypically and functionally overlapping subsets of dendritic cells (DCs) and monocytes, but the extent of their heterogeneity and distinct markers for subset identification remains elusive. By integrating high-dimensional single-cell protein and RNA expression data, we identified distinct markers to delineate monocytes from conventional DC2 (cDC2s). Using CD88 and CD89 for monocytes and HLA-DQ and FcεRIα for cDC2s allowed for their specific identification in blood and tissues. We also showed that cDC2s could be subdivided into phenotypically and functionally distinct subsets based on CD5, CD163, and CD14 expression, including a distinct subset of circulating inflammatory CD5−CD163+CD14+ cells related to previously defined DC3s. These inflammatory DC3s were expanded in systemic lupus erythematosus patients and correlated with disease activity. These findings further unravel the heterogeneity of DC subpopulations in health and disease and may pave the way for the identification of specific DC subset-targeting therapies. Using high-dimensional protein and RNA single-cell analyses, Dutertre et al. analyze human dendritic cell and monocyte subsets and identify markers that delineate them and unravel their heterogeneity. They also reveal the presence of inflammatory CD14+ DC3s, a subset of cDC2s, that correlate with disease progression and may be functionally involved in systemic lupus erythematosus immunopathology.
KW - CD88
KW - CD89
KW - DC2
KW - DC3
KW - FcεRIα
KW - SLE
KW - dendritic cell
KW - inflammatory DC
KW - lupus
KW - monocyte
KW - pre-DC
UR - http://www.scopus.com/inward/record.url?scp=85072167825&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2019.08.008
DO - 10.1016/j.immuni.2019.08.008
M3 - Article
C2 - 31474513
AN - SCOPUS:85072167825
SN - 1074-7613
VL - 51
SP - 573-589.e8
JO - Immunity
JF - Immunity
IS - 3
ER -